Join our community of smart investors

Smith & Nephew to acquire Osiris

The medical devices giant has agreed a $660m takeover in the US
March 13, 2019

We had speculated that medical devices giant Smith & Nephew (SN.) might look to reinvigorate sales growth with acquisitions. We have not had long to wait since tipping the shares a month ago. The group has announced the acquisition of Maryland-based Osiris Therapeutics for $19 (14.5p) a share, or $660m in total.

IC TIP: Buy at 1,473p
This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in